ARTICLE | Clinical News
G-202 regulatory update
March 18, 2013 7:00 AM UTC
GenSpera said FDA granted Orphan Drug designation for G-202 to treat hepatocellular carcinoma (HCC). The prodrug of plant-derived cytotoxin 12ADT is in Phase II testing to treat advanced, progressive ...